Weis Markets has completed a full deployment of Toshiba Global Commerce Solutions’ ELERA Security Suite across its store ...
In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...
Expands long-standing relationship; adds new Professional Services on top of licensing increaseSupports enterprise-wide Data ...
Navigate rising financial and cyber fraud with forensic accounting solutions that improve transparency and risk management ...
Pfizer Inc. is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire ...
Automation and Artificial Intelligence (AI) are being heavily utilized for loss prevention at major retailers, according to a new study by Zebra Technology Corporation. The study found that 87% of ...
Warner Bros. Discovery swung to loss of $148 million and saw total revenue decline 6% to $9.05 billion in its third quarter of 2025 as the media giant dangles a “for sale” sign for all or parts of the ...
Metro One Loss Prevention Services (Guard Division NY), Inc., The Loss Prevention Group, Inc.
The semicolon is a small symbol with a big meaning: To pause, not end. We learn about some local companies who are advocating for suicide awareness and prevention with a semicolon sweatshirt ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Merck, which has claimed ...
GLP-1 drugs were initially developed for type 2 diabetes but are now widely used to treat obesity. Novo Nordisk and Eli Lilly lead in GLP-1 drug production, with others like Viking Therapeutics ...
Eli Lilly has sued two compounding pharmacies for allegedly producing replicas of its diabetes and weight loss drugs. Eli Lilly has sued companies in 34 states on similar claims, alleging they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results